| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.51B | 49.13B | 46.20B | 45.23B | 44.86B | 40.12B |
| Gross Profit | 12.58B | 12.71B | 12.07B | 11.56B | 12.01B | 10.34B |
| EBITDA | 6.96B | 8.04B | 7.44B | 7.37B | 7.25B | 5.36B |
| Net Income | 4.42B | 4.45B | 4.01B | 3.72B | 4.21B | 2.93B |
Balance Sheet | ||||||
| Total Assets | 77.20B | 77.60B | 65.32B | 67.48B | 57.57B | 51.99B |
| Cash, Cash Equivalents and Short-Term Investments | 9.74B | 13.22B | 9.71B | 6.63B | 4.81B | 4.32B |
| Total Debt | 1.00B | 1.00B | 1.00B | 1.00B | 1.50B | 1.63B |
| Total Liabilities | 24.49B | 24.70B | 19.13B | 20.71B | 19.33B | 17.77B |
| Stockholders Equity | 52.71B | 52.90B | 46.20B | 46.77B | 38.24B | 34.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.06B | 4.66B | 2.81B | 1.11B | 997.00M |
| Operating Cash Flow | 0.00 | 7.61B | 6.07B | 4.83B | 3.87B | 2.94B |
| Investing Cash Flow | 0.00 | -2.40B | -1.31B | -1.98B | -2.81B | -1.69B |
| Financing Cash Flow | 0.00 | -1.78B | -1.77B | -1.12B | -691.00M | -965.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥42.97B | 10.29 | ― | 2.86% | 4.66% | 19.39% | |
78 Outperform | ¥33.57B | 12.50 | ― | 1.90% | 2.15% | 16.14% | |
77 Outperform | ¥7.32B | 6.31 | ― | 1.96% | 8.43% | 2.99% | |
75 Outperform | ¥23.09B | 9.28 | ― | 3.82% | 8.02% | 42.17% | |
69 Neutral | ¥79.75B | 15.55 | ― | 2.35% | 6.95% | 8.85% | |
64 Neutral | ¥87.95B | 19.32 | ― | 3.41% | 5.84% | -67.78% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |